Human CD8+ T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells

European Journal of Immunology

Volumn 31, Issue 2, 2001, Pages 459-466

  Speiser, Daniel E ^a,e   Migliaccio, Marco ^a,b,c   Pittet, Mikaël J ^a   Valmori, Danila ^a   Liénard, Danielle ^a   Lejeune, Ferdy ^a   Reichenbach, Patrick ^c   Guillaume, Philippe ^a   Lüscher, Immanuel ^d   Cerottini, Jean Charles ^a,d   Romero, Pedro ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^e Hopital Orthopedique de la Suisse Romande   (Switzerland)

Author keywords

CD28; CD8+ T lymphocyte; Cytotoxicity; HLA DR; Telomerase

Indexed keywords

CD28 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CELL SURFACE MARKER; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; TELOMERASE;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL SELECTION; CELL SEPARATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TELOMERE;

ANTIGENS, CD27; ANTIGENS, CD28; ANTIGENS, CD56; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HLA-DR ANTIGENS; HUMANS; KI-67 ANTIGEN; LYMPHOCYTE ACTIVATION; TELOMERASE;

EID: 0035104970     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200102)31:2<459::AID-IMMU459>3.0.CO;2-Y     Document Type: Article

References (40)

1. T cell activation determined by T cell receptor number and tunable thresholds
2. Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells
3. Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: Human CD8 memory CTLp selectively express CD45RO (UCHL1)
4. The role of the CD28 receptor during T cell responses to antigen
5. CD28/B7 system of T cell costimulation
6. CD27: Marker and mediator of T-cell activation?
7. T cell antigen receptor signal transduction pathways
8. Biology of the interleukin-2 receptor
9. + cells with different requirements for activation and differentiation
10. + T-cell memory, CD45 R subsets and the persistence of antigen - A unifying concept
11. CD28- T lymphocytes. Antigenic and functional properties
12. + T cells
13. + T cells closely correlates with CD56 surface expression
14. Extension of life-span by introduction of telomerase into normal human cells
15. Telomerase activity in normal and malignant hematopoietic cells
16. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
17. Telomerase regulation during entry into the cell cycle in normal human T cells
18. Tales of tails: Regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation and aging
19. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality
20. + T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: A mechanism for rescue from replicative senescence
21. + counterparts
22. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point a high turnover of hematopoietic stem cells and memory T cells in early childhood
23. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
24. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells
25. Signal-dependent membrane protein trafficking in the endocytic pathway
26. Transferrin receptor expression as a marker of immature cycling thymocytes in the mouse
27. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
28. + T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection
29. + T cells following vaccination with antigenic peptide
30. Analysis of accessory signaling in human T-cell clones
31. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains
32. + T cell clones in elderly humans
33. + cytotoxic T cells express CD38 and HLA-DR antigens
34. + T cells during the primary immune response to Epstein-Barr Virus in vivo
35. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus
36. Immunopathology or organ-specific autoimmunity as a consequence of virus infection
37. Phenotypic analysis of antigen-specific T lymphocytes
38. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytotoxic T lymphocytes
39. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)
40. Rapid induction of cytolytic T cells via CD28 stimulation for cellular immunotherapy